Cargando…

Therapeutic Implications of the Drug Resistance Conferred by Extracellular Vesicles Derived from Triple-Negative Breast Cancer Cells

Anticancer drug resistance is a significant impediment in current cancer treatment. Extracellular vesicles (EVs) derived from cancer cells were recently acknowledged as a critical mechanism of drug resistance, tumor progression, and metastasis. EVs are enveloped vesicles comprising a lipid bilayer t...

Descripción completa

Detalles Bibliográficos
Autor principal:	Yi, Yong Weon
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9960576/ https://www.ncbi.nlm.nih.gov/pubmed/36835116 http://dx.doi.org/10.3390/ijms24043704

Ejemplares similares

Applications of Extracellular Vesicles in Triple-Negative Breast Cancer
por: St-Denis-Bissonnette, Frederic, et al.
Publicado: (2022)

Extracellular Vesicles as a New Therapeutic Entity
por: Yi, Yong Weon
Publicado: (2023)

Extracellular vesicles from triple-negative breast cancer cells promote proliferation and drug resistance in non-tumorigenic breast cells
por: Ozawa, Patricia Midori Murobushi, et al.
Publicado: (2018)

Extracellular Vesicles: The Landscape in the Progression, Diagnosis, and Treatment of Triple-Negative Breast Cancer
por: Dong, Menglu, et al.
Publicado: (2022)

miR-134 in extracellular vesicles reduces triple-negative breast cancer aggression and increases drug sensitivity
por: O'Brien, Keith, et al.
Publicado: (2015)

Protein and chemotherapy profiling of extracellular vesicles harvested from therapeutic induced senescent triple negative breast cancer cells
por: Kavanagh, E L, et al.
Publicado: (2017)

Extracellular Vesicles in Triple–Negative Breast Cancer: Immune Regulation, Biomarkers, and Immunotherapeutic Potential
por: Das, Kaushik, et al.
Publicado: (2023)

An extensive study of potential inhibitors of extracellular vesicles release in triple-negative breast cancer
por: McNamee, Niamh, et al.
Publicado: (2023)

The Therapeutic Potential of Breast Milk-Derived Extracellular Vesicles
por: Galley, Jeffrey D., et al.
Publicado: (2020)

Potentiating Therapeutic Effects of Epidermal Growth Factor Receptor Inhibition in Triple-Negative Breast Cancer
por: You, Kyu Sic, et al.
Publicado: (2021)

The roles of small extracellular vesicles as prognostic biomarkers and treatment approaches in triple-negative breast cancer
por: Zhou, Yueyuan, et al.
Publicado: (2022)

The history of small extracellular vesicles and their implication in cancer drug resistance
por: Palazzolo, Stefano, et al.
Publicado: (2022)

Extracellular Vesicles in Cancer Drug Resistance: Implications on Melanoma Therapy
por: Musi, Alice, et al.
Publicado: (2023)

Extracellular Vesicles in Cancer Drug Resistance: Roles, Mechanisms, and Implications
por: Yang, Qiurong, et al.
Publicado: (2022)

Tumor-Derived Small Extracellular Vesicles Involved in Breast Cancer Progression and Drug Resistance
por: Feng, Lingyun, et al.
Publicado: (2022)

Emerging Therapeutic Drugs in Metastatic Triple-Negative Breast Cancer
por: Cipriano, Élia, et al.
Publicado: (2021)

Cancer Testis Antigen Promotes Triple Negative Breast Cancer Metastasis and is Traceable in the Circulating Extracellular Vesicles
por: Kannan, Anbarasu, et al.
Publicado: (2019)

Lipidomic Analysis of Cells and Extracellular Vesicles from High- and Low-Metastatic Triple-Negative Breast Cancer
por: Nishida-Aoki, Nao, et al.
Publicado: (2020)

Eribulin and Paclitaxel Differentially Alter Extracellular Vesicles and Their Cargo from Triple-Negative Breast Cancer Cells
por: Pederson, Petra J., et al.
Publicado: (2021)

Focus on Extracellular Vesicles: Therapeutic Potential of Stem Cell-Derived Extracellular Vesicles
por: Zhang, Bin, et al.
Publicado: (2016)

Extracellular Vesicle-Mediated Purinergic Signaling Contributes to Host Microenvironment Plasticity and Metastasis in Triple Negative Breast Cancer
por: Duan, Suzann, et al.
Publicado: (2021)

Identification of three subtypes of triple-negative breast cancer with potential therapeutic implications
por: Jézéquel, Pascal, et al.
Publicado: (2019)

Plant-Derived Extracellular Vesicles as Therapeutic Nanocarriers
por: Karamanidou, Theodora, et al.
Publicado: (2021)

Mitochondrial-Derived Vesicles—Link to Extracellular Vesicles and Implications in Cardiovascular Disease
por: Heyn, Jonas, et al.
Publicado: (2023)

SYTL4 downregulates microtubule stability and confers paclitaxel resistance in triple-negative breast cancer
por: Liu, Xi-Yu, et al.
Publicado: (2020)

Author Correction: Cancer Testis Antigen Promotes Triple Negative Breast Cancer Metastasis and is Traceable in the Circulating Extracellular Vesicles
por: Kannan, Anbarasu, et al.
Publicado: (2020)

The potential role of cofilin-1 in promoting triple negative breast cancer (TNBC) metastasis via the extracellular vesicles (EVs)
por: Howard, Jane, et al.
Publicado: (2021)

Case Report: Analysis of Plasma Extracellular Vesicles in a Triple Negative Spindle-Cell Metaplastic Breast Cancer Patient
por: Vannini, Ivan, et al.
Publicado: (2022)

Extracellular vesicles from triple negative breast cancer promote pro-inflammatory macrophages associated with better clinical outcome
por: Tkach, Mercedes, et al.
Publicado: (2022)

Small Extracellular Vesicles from Hypoxic Triple-Negative Breast Cancer Cells Induce Oxygen-Dependent Cell Invasion
por: Pachane, Bianca Cruz, et al.
Publicado: (2022)

Drug resistance profiling of a new triple negative breast cancer patient-derived xenograft model
por: Matossian, Margarite D., et al.
Publicado: (2019)

The Prognostic and Therapeutic Implications of the Chemoresistance Gene BIRC5 in Triple-Negative Breast Cancer
por: Adinew, Getinet M., et al.
Publicado: (2022)

Breast Cancer Derived Extracellular Vesicles in Bone Metastasis Induction and Their Clinical Implications as Biomarkers
por: Taverna, Simona, et al.
Publicado: (2020)

Combined drug therapeutic strategies for the effective treatment of Triple Negative Breast Cancer
por: Chalakur-Ramireddy, Naveen K.R., et al.
Publicado: (2018)

Stemness signature and targeted therapeutic drugs identification for Triple Negative Breast Cancer
por: Gul, Samina, et al.
Publicado: (2023)

Inhibition of IκB Kinase Is a Potential Therapeutic Strategy to Circumvent Resistance to Epidermal Growth Factor Receptor Inhibition in Triple-Negative Breast Cancer Cells
por: Yi, Yong Weon, et al.
Publicado: (2022)

Triple-negative breast cancer: understanding Wnt signaling in drug resistance
por: Merikhian, Parnaz, et al.
Publicado: (2021)

Mesenchymal Stem Cell‐Derived Extracellular Vesicles as Therapeutics and as a Drug Delivery Platform
por: Baek, Gyuhyeon, et al.
Publicado: (2019)

A new ALK isoform transported by extracellular vesicles confers drug resistance to melanoma cells
por: Cesi, Giulia, et al.
Publicado: (2018)

Stem Cell-Derived Extracellular Vesicles as Immunomodulatory Therapeutics
por: Seo, Yoojin, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_2cloofv40l4dqe2rfoisvt3957